• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贲门失弛缓症伴密集嗜酸性粒细胞浸润对类固醇治疗有反应。

Achalasia with dense eosinophilic infiltrate responds to steroid therapy.

机构信息

Division of Gastroenterology, Department of Internal Medicine, University of Genoa, Genoa, Italy.

出版信息

Clin Gastroenterol Hepatol. 2011 Dec;9(12):1104-6. doi: 10.1016/j.cgh.2011.08.002. Epub 2011 Aug 11.

DOI:10.1016/j.cgh.2011.08.002
PMID:21839711
Abstract

A patient presented with chronic substernal discomfort and intermittent dysphagia for solids. High-resolution impedance manometry (HRIM) of the esophagus showed that there was no peristalsis in the esophageal body but incomplete relaxation of the lower esophageal sphincter and incomplete bolus transit, so the patient was diagnosed with achalasia. Moreover, probably because of esophageal stasis, eosinophilic infiltration that mimicked a pattern of eosinophilic esophagitis was observed, on the basis of multiple biopsies of the esophagus. The patient was given 50 mg prednisolone once daily; the symptoms improved dramatically, and HRIM showed complete recovery of esophageal peristalsis, deeper relaxation of the lower esophageal sphincter, and complete bolus transit profile. HRIM can therefore be used to assess dysmotility abnormalities in patients with achalasia and eosinophilic-like esophagitis, and steroids relieve these symptoms. Treatment with a high dose of prednisolone resulted in a complete disappearance of dysphagia because of improved esophageal motility and reduced eosinophilic infiltrate. It is therefore important to control the inflammatory process in patients with idiopathic achalasia, which is likely to result from an autoimmune reaction.

摘要

一位患者表现为慢性胸骨后不适和间歇性固体食物吞咽困难。食管高分辨率阻抗测压(HRIM)显示食管体无蠕动,但食管下括约肌不完全松弛和不完全食团通过,因此诊断为贲门失弛缓症。此外,可能由于食管淤滞,在食管的多次活检中观察到类似于嗜酸性食管炎的嗜酸性粒细胞浸润模式。患者给予 50 毫克泼尼松龙每日一次;症状显著改善,HRIM 显示食管蠕动完全恢复,食管下括约肌松弛更深,完全通过食团轮廓。因此,HRIM 可用于评估贲门失弛缓症和嗜酸性食管炎患者的运动障碍异常,类固醇可缓解这些症状。高剂量泼尼松龙治疗导致吞咽困难完全消失,因为食管运动得到改善,嗜酸性粒细胞浸润减少。因此,控制特发性贲门失弛缓症患者的炎症过程很重要,这可能是由于自身免疫反应引起的。

相似文献

1
Achalasia with dense eosinophilic infiltrate responds to steroid therapy.贲门失弛缓症伴密集嗜酸性粒细胞浸润对类固醇治疗有反应。
Clin Gastroenterol Hepatol. 2011 Dec;9(12):1104-6. doi: 10.1016/j.cgh.2011.08.002. Epub 2011 Aug 11.
2
Esophageal motor abnormalities in eosinophilic esophagitis identified by high-resolution manometry.高分辨率测压法在嗜酸性粒细胞性食管炎中发现的食管运动异常。
J Gastroenterol Hepatol. 2011 Sep;26(9):1447-50. doi: 10.1111/j.1440-1746.2011.06770.x.
3
Esophageal motility in eosinophilic esophagitis.嗜酸性粒细胞性食管炎的食管动力
Rev Gastroenterol Mex. 2015 Jul-Sep;80(3):205-13. doi: 10.1016/j.rgmx.2015.05.005. Epub 2015 Aug 12.
4
Manometric findings in adult eosinophilic oesophagitis: a study of 12 cases.成人嗜酸性粒细胞性食管炎的测压结果:一项12例病例的研究。
Eur J Gastroenterol Hepatol. 2007 May;19(5):417-24. doi: 10.1097/MEG.0b013e328010bd69.
5
Uses of esophageal function testing: dysphagia.食管功能测试的用途:吞咽困难。
Gastrointest Endosc Clin N Am. 2014 Oct;24(4):643-54. doi: 10.1016/j.giec.2014.06.008. Epub 2014 Aug 10.
6
Esophageal achalasia--manometric patterns.食管失弛缓症——测压模式
Rom J Intern Med. 2009;47(3):243-7.
7
Eosinophilic esophagitis in a patient with vigorous achalasia.
Gastroenterology. 1978 Jun;74(6):1298-1301.
8
Regional esophageal dysfunction in scleroderma and achalasia using multichannel intraluminal impedance and manometry.利用多通道腔内阻抗和测压法研究硬皮病和贲门失弛缓症中的食管局部功能障碍
Dig Dis Sci. 2008 Jan;53(1):210-6. doi: 10.1007/s10620-007-9845-x. Epub 2007 Jun 5.
9
Eosinophilic esophagitis in patients with esophageal atresia and chronic dysphagia.食管闭锁和慢性吞咽困难患者的嗜酸性粒细胞性食管炎
World J Gastroenterol. 2014 Dec 21;20(47):18038-43. doi: 10.3748/wjg.v20.i47.18038.
10
Return of esophageal peristalsis after nifedipine therapy in patients with idiopathic esophageal achalasia.硝苯地平治疗特发性食管失弛缓症患者后食管蠕动的恢复
Am J Gastroenterol. 1992 Dec;87(12):1705-8.

引用本文的文献

1
Response Rate to Treatment of Achalasia Patients With Thyroid Disorders Versus Euthyroid Patients: A Cross-Sectional Study in Iran.甲状腺疾病患者与甲状腺功能正常患者贲门失弛缓症治疗的反应率:伊朗的一项横断面研究。
JGH Open. 2025 Aug 11;9(8):e70197. doi: 10.1002/jgh3.70197. eCollection 2025 Aug.
2
Manometric findings in children with eosinophilic esophagitis and persistent post-remission dysphagia.嗜酸性粒细胞性食管炎及缓解后持续性吞咽困难患儿的测压结果
JPGN Rep. 2024 May 22;5(3):289-295. doi: 10.1002/jpr3.12083. eCollection 2024 Aug.
3
Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes.
嗜酸性食管炎成人患者的最佳评估、治疗及监测:改善预后的策略
Immunotargets Ther. 2024 Jul 24;13:367-383. doi: 10.2147/ITT.S276869. eCollection 2024.
4
Achalasia alters physiological networks depending on sex.贲门失弛缓症根据性别改变生理网络。
Sci Rep. 2024 Jan 24;14(1):2072. doi: 10.1038/s41598-024-52273-3.
5
The Crucial Role of the Interstitial Cells of Cajal in Neurointestinal Diseases.Cajal间质细胞在神经肠道疾病中的关键作用
Biomolecules. 2023 Sep 7;13(9):1358. doi: 10.3390/biom13091358.
6
Achalasia is Strongly Associated With Eosinophilic Esophagitis and Other Allergic Disorders.贲门失弛缓症与嗜酸性食管炎和其他过敏性疾病密切相关。
Clin Gastroenterol Hepatol. 2024 Jan;22(1):34-41.e2. doi: 10.1016/j.cgh.2023.06.013. Epub 2023 Jun 28.
7
Eosinophils Infiltration in Esophageal Muscularis Propria Induces Achalasia-like Esophageal Motility Disorder in Mice.嗜酸性粒细胞浸润食管固有肌层导致小鼠类似贲门失弛缓症的食管运动障碍。
Biomolecules. 2022 Dec 13;12(12):1865. doi: 10.3390/biom12121865.
8
Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications.嗜酸性粒细胞性食管炎患者的食管动力障碍:发病机制、评估工具、测压特征和临床意义。
Esophagus. 2023 Jan;20(1):29-38. doi: 10.1007/s10388-022-00964-z. Epub 2022 Oct 11.
9
Achalasia.贲门失弛缓症。
Nat Rev Dis Primers. 2022 May 5;8(1):28. doi: 10.1038/s41572-022-00356-8.
10
Dysmotility in Eosinophilic Esophagitis.嗜酸性粒细胞性食管炎中的动力障碍
Front Pediatr. 2022 Feb 28;10:853754. doi: 10.3389/fped.2022.853754. eCollection 2022.